HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest Articles

Latest from PR Newswire

Click here to access further cosmetics and dietary supplement news.

Health Explore this Topic

Set Alert for Health

Latest From Health

Homeopathics, Supplements, OTC Medicines Overlap In Pharmacists’ ‘Over-The-Counter’ Survey

Results of U.S. News & World Report’s first “Best OTC Medicine & Health Products” survey include homeopathic formulations, supplements and non-drug topicals in same categories of indications with nonprescription pharmaceuticals.

Consumer Market Intelligence

People On The Move: Appointments At AESGP, Alliance Pharma, FSE, Venture Life

A round-up of the latest appointments in Europe's consumer health industry: AESGP names Haleon's Workman as president; Alliance Pharma shareholders re-elect board; Food Supplements Europe re-elects Stada's Šímová as chair; and Venture Life announces departure of co-Founder and CCO Daly.

Europe Executive Changes

Health And Wellness Weekly Trademarks Review: 23 May

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

OTC Drugs Trademarks

Longer Exclusivity Periods For EU Centralized Rx-To-OTC Switches? Commission Says No

One way to revitalize interest in the EU's centralized switch procedure would be to introduce longer data exclusivity periods or market exclusivity for successful applicants, concluded an AESGP expert switch panel presenting at the association's 59th Annual Meeting in Paris, France. However, a European Commission representative told another panel that this was not under consideration as part of the EU pharmaceutical legislation revision.

Europe Health

Pending Decision On First US OTC Birth Control Shines Spotlight On Self-Report Study Data

Approval likely would account for all weight on scale of FDA decision if not for self-report element in design of HRA Pharma’s actual use study for OTC switch of 0.075-mg norgestrel branded Opill. HRA’s sNDA offers lesson for using electronic diary apps in self-report studies.

FDA Prescription To OTC Switch

AESGP Annual Meeting: OTC Antifungals, Antivirals Could Become Rx In EU

The European Commission shocked participants at this year's AESGP Annual Meeting by warning that OTC antifungals, like treatments for athlete’s foot, and OTC antivirals, like cold sore creams, could soon become prescription-only within the region, under proposed revisions to the EU pharma legislation. There is hope, however. The proposals are still open to feedback from industry, the AESGP points out, and even if this proposal becomes law, member states can waive this prescription requirement under certain conditions.

Europe Health
See All

Beauty Explore this Topic

Set Alert for Beauty

Latest From Beauty

E.l.f. Facing Off Against Beauty Giants: Third Among Mass Market Brands As Sales Jump 78%

E.l.f. cosmetics climbed to No. 3 brand in US mass market cosmetics, up two slots from a year ago as it surpassed Revlon and CoverGirl. In its recent sales and earnings presentation, it announced sales in its fiscal 2023 fourth quarter jumped 78%.

US States Beauty

Homeopathics, Supplements, OTC Medicines Overlap In Pharmacists’ ‘Over-The-Counter’ Survey

Results of U.S. News & World Report’s first “Best OTC Medicine & Health Products” survey include homeopathic formulations, supplements and non-drug topicals in same categories of indications with nonprescription pharmaceuticals.

Consumer Market Intelligence

Cosmetics Industry’s Preservatives Crisis Grows More Dire Under New Washington State Law

Washington State Governor Jay Inslee signed into law HB 1047 on 15 May, implementing the most aggressive cosmetics ingredient ban in the country. The Personal Care Products Council and Independent Beauty Association are concerned about a lack of alternative preservatives to replace targeted formaldehyde-releasing substances effectively and affordably and the law’s inconsistency with FDA over lead levels, among other impacts.

US States Beauty

Cosmetic And Personal Care Weekly Trademarks Review: 23 May

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches

Perfect Corp. Highlights Results Of AR-Based Nail Color Sampling At Sally Hansen

Sally Hansen has seen a 300% increase in shades viewed on its website, and a 120% increase in intent to buy, since it introduced Perfect Corp.’s AR-based virtual try-on tool, the beauty tech firm says. French nail-color specialist Manicurist is the latest to partner with Perfect for its Green Flash brand.

Advertising, Marketing & Sales Deals

House Appropriations Subcommittee Proposes FDA FY2024 Budget $662M Short Of Request

Appropriations Agriculture, Rural Development, FDA and Related Agencies Subcommittee marked up its FY2024 bill on 18 May, proposing $6.579bn for FDA. Total is up from current budget of $6.562bn, but Biden administration proposed $7.2bn for FY2024.

FDA Consumer
See All

Wellness Explore this Topic

Set Alert for Wellness

Latest From Wellness

Algae With Claimed Immunity Benefits Gets EU Nod For Supplement Use

An algae extract that is claimed to support the immune system while helping to protect against oxidative stress has obtained a positive opinion as a novel food in the European Union.

Europe Wellness

US Hemp Industry Group Rings Alarm With Congress About FDA’s Safety Conclusions

US Hemp Roundtable general counsel cautions congressional leaders about “agency’s misguided use of incomplete safety data as the basis for its continued refusal to regulate CBD as a dietary supplement or food additive.”

Cannabidiol CBD FDA

Stada’s Natures Aid Expands UK Children’s Wellness Lines

Stada Arzneimittel’s UK dietary supplement subsidiary Natures Aid is expanding its Mini Drops and Super Stars children’s wellness brands with new products.

United Kingdom Wellness

Homeopathics, Supplements, OTC Medicines Overlap In Pharmacists’ ‘Over-The-Counter’ Survey

Results of U.S. News & World Report’s first “Best OTC Medicine & Health Products” survey include homeopathic formulations, supplements and non-drug topicals in same categories of indications with nonprescription pharmaceuticals.

Consumer Market Intelligence

People On The Move: Appointments At AESGP, Alliance Pharma, FSE, Venture Life

A round-up of the latest appointments in Europe's consumer health industry: AESGP names Haleon's Workman as president; Alliance Pharma shareholders re-elect board; Food Supplements Europe re-elects Stada's Šímová as chair; and Venture Life announces departure of co-Founder and CCO Daly.

Europe Executive Changes

Health And Wellness Weekly Trademarks Review: 23 May

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

OTC Drugs Trademarks
See All

Market Intelligence Explore this Topic

Set Alert for Market Intelligence

Latest From Market Intelligence

Homeopathics, Supplements, OTC Medicines Overlap In Pharmacists’ ‘Over-The-Counter’ Survey

Results of U.S. News & World Report’s first “Best OTC Medicine & Health Products” survey include homeopathic formulations, supplements and non-drug topicals in same categories of indications with nonprescription pharmaceuticals.

Consumer Market Intelligence

Longer Exclusivity Periods For EU Centralized Rx-To-OTC Switches? Commission Says No

One way to revitalize interest in the EU's centralized switch procedure would be to introduce longer data exclusivity periods or market exclusivity for successful applicants, concluded an AESGP expert switch panel presenting at the association's 59th Annual Meeting in Paris, France. However, a European Commission representative told another panel that this was not under consideration as part of the EU pharmaceutical legislation revision.

Europe Health

AESGP Annual Meeting: OTC Antifungals, Antivirals Could Become Rx In EU

The European Commission shocked participants at this year's AESGP Annual Meeting by warning that OTC antifungals, like treatments for athlete’s foot, and OTC antivirals, like cold sore creams, could soon become prescription-only within the region, under proposed revisions to the EU pharma legislation. There is hope, however. The proposals are still open to feedback from industry, the AESGP points out, and even if this proposal becomes law, member states can waive this prescription requirement under certain conditions.

Europe Health
See All
UsernamePublicRestriction

Register